Artiva Biotherapeutics, Inc.
Ticker: ARTV
| Insider | Title |
|---|---|
| Alison Moore | Director |
| Andrew J. Schwab | 10% or greater ownership |
| Biomedical Innovation Master Investors (cayman) I L.p. Wellington | 10% or greater ownership |
| Brian Daniels | Director |
| Capital Healthcare Fund Lp Ra | Director, 10% or greater ownership |
| Capital Management, L.p. Ra | Director, 10% or greater ownership |
| Capital Nexus Fund Iii, L.p. Ra | Director |
| Capital Nexus Fund, L.p. Ra | Director |
| Cell Corp Gc | 10% or greater ownership |
| Christopher Horan | Chief Tech Operations Officer |
| Corey S Goodman | 10% or greater ownership |
| Corp. Gc | 10% or greater ownership |
| Elizabeth L Hougen | Director |
| Fred Aslan | President and CEO, Director |
| Gines Diego Miralles | Director |
| Global Strategic Fund Iii, L.p. Venbio | 10% or greater ownership |
| Global Strategic Gp Iii, L.p. Venbio | 10% or greater ownership |
| Global Strategic Gp Iii, Ltd Venbio | 10% or greater ownership |
| Heather Raymon | SVP, Research and Development |
| Jennifer Bush | COO, CLO, Secy, Compliance Off |
| Kush Parmar | 10% or greater ownership |
| Laura Bessen | Director |
| Laura Stoppel | Director |
| Neha Krishnamohan | Chief Financial Officer |
| Opportunities Ii (gp), Llc 5am | 10% or greater ownership |
| Opportunities Ii, L.p. 5am | 10% or greater ownership |
| Partners Vi, Llc 5am | 10% or greater ownership |
| Peter Kolchinsky | Director, 10% or greater ownership |
| Rajeev M. Shah | Director, 10% or greater ownership |
| Robert J Adelman | 10% or greater ownership |
| Thorsten Graef | Chief Medical Officer |
| Ventures Vi, L.p. 5am | 10% or greater ownership |
| Yong-jun Huh | Director |